tiprankstipranks
Advertisement
Advertisement

RGEN Stock Latest News

Apple upgraded, Qualcomm downgraded: Wall Street’s top analyst calls
The FlyApple upgraded, Qualcomm downgraded: Wall Street’s top analyst calls
3d ago
SR
CLX
Repligen opens new Training & Innovation Center in Netherlands
PremiumThe Fly
Repligen opens new Training & Innovation Center in Netherlands
3d ago
RGEN
Repligen initiated with a Buy at Rothschild & Co Redburn
PremiumThe Fly
Repligen initiated with a Buy at Rothschild & Co Redburn
3d ago
RGEN
Repligen price target lowered to $145 from $175 at Barclays
PremiumThe Fly
Repligen price target lowered to $145 from $175 at Barclays
6d ago
RGEN
Repligen price target lowered to $140 from $170 at Evercore ISI
PremiumThe Fly
Repligen price target lowered to $140 from $170 at Evercore ISI
14d ago
RGEN
Repligen: Strong Execution, Innovation, and Cross‑Selling Momentum Support Sustained Growth and Reaffirmed Buy Rating
PremiumRatingsRepligen: Strong Execution, Innovation, and Cross‑Selling Momentum Support Sustained Growth and Reaffirmed Buy Rating
28d ago
RGEN
Repligen price target raised to $208 from $180 at H.C. Wainwright
Premium
The Fly
Repligen price target raised to $208 from $180 at H.C. Wainwright
28d ago
RGEN
Repligen price target lowered to $195 from $200 at UBS
Premium
The Fly
Repligen price target lowered to $195 from $200 at UBS
2M ago
RGEN
Repligen price target lowered to $170 from $180 at Evercore ISI
PremiumThe Fly
Repligen price target lowered to $170 from $180 at Evercore ISI
2M ago
RGEN
Repligen: Solid Execution and Credible Growth Outlook, But Upside Limited at Current Valuation
PremiumRatings
Repligen: Solid Execution and Credible Growth Outlook, But Upside Limited at Current Valuation
2M ago
RGEN
Repligen price target lowered to $180 from $190 at Wells Fargo
PremiumThe Fly
Repligen price target lowered to $180 from $190 at Wells Fargo
2M ago
RGEN
Repligen price target lowered to $175 from $200 at Barclays
PremiumThe Fly
Repligen price target lowered to $175 from $200 at Barclays
2M ago
RGEN
Repligen Signals Confident Growth Path In 2026 Outlook
PremiumCompany AnnouncementsRepligen Signals Confident Growth Path In 2026 Outlook
2M ago
RGEN
Repligen: Cautious 2026 Guidance with Derisked Upside and Premium-Valuation Growth Justifying a Buy Rating
Premium
Ratings
Repligen: Cautious 2026 Guidance with Derisked Upside and Premium-Valuation Growth Justifying a Buy Rating
2M ago
RGEN
Repligen reports Q4 adjusted EPS 49c, consensus 44c
Premium
The Fly
Repligen reports Q4 adjusted EPS 49c, consensus 44c
2M ago
RGEN
Repligen sees FY26 EPS $1.93-$2.01, consensus $2.07
PremiumThe Fly
Repligen sees FY26 EPS $1.93-$2.01, consensus $2.07
2M ago
RGEN
RGEN Earnings this Week: How Will it Perform?
PremiumPre-Earnings
RGEN Earnings this Week: How Will it Perform?
2M ago
RGEN
Private Markets: Nvidia, Microsoft consider new investment in OpenAI
PremiumThe Fly
Private Markets: Nvidia, Microsoft consider new investment in OpenAI
3M ago
C
AI
Repligen price target raised to $200 from $190 at UBS
PremiumThe Fly
Repligen price target raised to $200 from $190 at UBS
3M ago
RGEN
Repligen Appoints Martin Madaus as New Board Chair
PremiumCompany AnnouncementsRepligen Appoints Martin Madaus as New Board Chair
3M ago
8K
RGEN
Repligen executive chair Tony Hunt to retire, Martin Madaus to succeed
Premium
The Fly
Repligen executive chair Tony Hunt to retire, Martin Madaus to succeed
3M ago
RGEN
Repligen announces launch of three high-performance resins
Premium
The Fly
Repligen announces launch of three high-performance resins
4M ago
RGEN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >